期刊文献+

胃癌组织中层黏连蛋白受体67LR和半乳糖凝集素-3蛋白的表达 被引量:5

Expression of 67LR and Galectin-3 in the patients with gastric carcinoma
下载PDF
导出
摘要 目的:了解胃癌组织中67000层黏连蛋白受体(67LR)和半乳糖凝集素-3(Galectin-3)蛋白的表达情况。方法:用免疫组织化学SP法检测82例胃癌组织和20例胃癌手术远端切缘正常胃组织中67LR蛋白和Galectin-3蛋白的表达,并分析其与胃癌患者临床病理特征的关系。结果:胃癌组织中67LR蛋白的阳性表达率为59.8%,Galectin-3蛋白的阳性表达率为84.1%,均高于相应的正常胃黏膜组织中的阳性表达率(30.0%和35.0%)。胃癌组织中67LR与Galectin-3蛋白的阳性表达率与患者的年龄、性别、Lauren分型无关;67LR蛋白的阳性表达率与胃癌的组织分化程度有关(P<0.05),Galectin-3蛋白的阳性表达率与胃癌的组织分化程度无关;有淋巴结转移的癌组织中两者的阳性表达率均高于无淋巴结转移组(P<0.05);随着肿瘤浸润深度的增加,两者的阳性表达率均明显增高(P<0.05)。胃癌组织中67LR与Galectin-3的表达呈正相关(P<0.05)。结论:67LR及Galectin-3蛋白阳性表达率与胃癌的侵袭、转移密切相关。 Aim : To study the expression of 67LR, galectin-3, and their relationships in patients with gastric carcinoma. Methods:The expression of 67LR and galectin-3 by immunohistochemical staining with the correspoding monoclonal antibodies, and their relation with the clinicopathologic characteristics were analyzed in 82 patients of primary gastric carcinoma. Gastric tissues were randomly collected from 20 patients as the controls which were gastric mucosas from the distant cutting margin. Results: The positive rate of expression of 67LR and galectin-3 were 59.8% (49/82) and 84.1% (69/82) in gastric cancer cases, respectively, whereas the epithelial ceils of gastric mucosas from the distant cutting margin had weak immunoreactivity which were 30.0% and 35.0% , respectively. The expression of 67LR and galectin-3 in gastric carcinogen tissues were not related to gender, age, and Lauren classification. The expression phenotype of 67LR but not Galectin-3 was correlated with cell differentiation. Moreover, the expression levels of 67LR and galectin-3 were stronger in gastric cancerous tissues with lymph node metastasis than that in the tissues with no lymph node metas'tasis( P 〈 0.05 ). Both of the 67LR and galectin-3 expression levels were significantly increased with the depth of tumor invasion ( P 〈 0.05 ). Conclusion : The expression of 67LR and galectin-3 might be closely associated with the invasion and metastasis of gastric cancer.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2009年第1期102-105,共4页 Journal of Zhengzhou University(Medical Sciences)
关键词 胃肿瘤 腺癌 层黏连蛋白受体 GALECTIN-3 侵袭 转移 gastric carcinoma 67LR Galectin-3 invasion metastasis
  • 相关文献

参考文献19

  • 1Gauczynski S, Peyrin JM, Haik S, et al. The 37-kDa/67- kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein[J]. EMBO J,2001,20(21): 5 863.
  • 2Miyazaki J, Hokari R, Kato S, et al. Increased expression of galectin-3 in primary gastric cancer and the metastatic lymph nodes[J]. Oncol Rep,2002,9(6) :1 307.
  • 3唐琳,张岚,李惠翔,郑湘予,张云汉,高冬玲.浸润转移胃癌组织中肝素酶基因的表达[J].郑州大学学报(医学版),2004,39(2):183-185. 被引量:3
  • 4Engbring JA, Kleinman HK. The basement membrane matrix in malignancy[ J]. J Pathol,2003,200(4) :465.
  • 5Pupa SM, Menard S, Forti S, et al. New insights into the role of extracellular matrix during tumor onset and progression [ J ]. J Cell Physiol, 2002,192 ( 3 ) : 259.
  • 6Nelson J, McFerran NV, Pivato G, et al. The 67 kDa laminin receptor: structure, function and role in disease [J]. Biosei Rep,2008,28( 1 ) :33.
  • 7Menard S, Tagliabue E, Colnaghi MI. The 67 kDa laminin receptor as a prognostic factor in human cancer[ J ]. Breast Cancer Res Treat, 1998,52 ( 1/3 ) : 137.
  • 8Colognato H, Yurchenco PD. Form and function:the laminin family of heterotrimers [ J ]. Dev Dyn, 2000,218 ( 2 ) : 213.
  • 9张楠,丁彦青,梁莉.Galectin-3在大肠癌组织中的表达及其临床意义[J].南方医科大学学报,2006,26(12):1685-1689. 被引量:15
  • 10Shimura T, Takenaka Y, Fukumori T, et al. Implication of galectin-3 in Wnt signaling[ J ]. Cancer Res,2005,65 (9) : 3 535.

二级参考文献29

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1361
  • 2Torii A, Kodera Y, Uesaka K, et al. Plasma concentration of matrix metalloproteinase 9 in gastric cancer. Br J Surg,1997,84(1) :133.
  • 3Eccles SA. Heparanase: breaking down barriers in tumors.Nat Med, 1999,5(7) :735.
  • 4Vlodavsky I, Friedmann Y. Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest, 2001,108(3) :341.
  • 5Gohji K, Katsuoka Y, Okamoto M, et al. Human heparanase: roles in invasion and metastasis of cancer. Hingokika kiyo, 2000,46(10) :757.
  • 6Vlodavsky I, Friedmann Y, Elkin M, et al. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med, 1999,5 (7) :793.
  • 7Hulett MD, Freeman C, Hamdorf BJ, et al. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med, 1999,5(7) :803.
  • 8Walch ET, Marchetti D. Role of neurotrophins and neurotrophins receptors in the in vitro invasion and heparanase production of human prostate cancer cells. Clin Exp Metastasis,1999,17 (4) :307.
  • 9Parish CR, Freeman C, Brown KJ, et al. Identification of sulfated oligosaeeharide-based inhibitors of tumor growth and metastasis using novel in vitro for angiogenesis and heparanase activity. Cancer Ries, 1999,59 (14) :3433.
  • 10Akahani S,Nangia-Makker P,Inohara H,et al.Galectin-3:a novel antiapoptotic molecule with a functional BHI (nwgr) domain of Bcl-2 family[J].Cancer Res,1997,57:5272-6.

共引文献16

同被引文献37

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部